Search

Search Constraints

You searched for: Author/Creator Kapiteijn, E.

Search Results

1. 31P The IOpener study: Tyrosine kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer. (December 2022)

2. 52. Resection of the primary tumour for asymptomatic incurable metastatic colorectal cancer – A EURECCA international comparison. Issue 9 (September 2016)

3. 6P Response and survival according to the interferon-gamma (IFN-γ) signature and tumor mutational burden (tmb) in the PRADO trial testing neoadjuvant ipilimumab and nivolumab in stage III melanoma. (December 2022)

5. Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls. (2nd January 2021)

6. Quality of life after curative resection for rectal cancer in patients treated with adjuvant chemotherapy compared with observation: results of the randomized phase III SCRIPT trial. Issue 2 (February 2019)

8. Survival of stage IV melanoma in Belgium and the Netherlands. (30th September 2021)

9. Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry. (February 2021)

10. Time trends in treatment strategies and survival of older versus younger patients with synchronous metastasized melanoma – a population-based study in the Netherlands Cancer Registry. (December 2021)